Molecular Pharmaceutics
[ASAP] Recent Advances in Peptides-Based Stimuli-Responsive Materials for Biomedical and Therapeutic Applications: A Review
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00983
Molecular Pharmaceutics
[ASAP] Novel 5‑Fluorouracil Carbonate-Loaded Liposome: Preparation, <italic toggle=”yes”>In Vitro</italic>, and <italic toggle=”yes”>In Vivo</italic> Evaluation as an Antitumor Agent
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.1c00820
Molecular Pharmaceutics
[ASAP] Prediction and Preparation of Coamorphous Phases of a Bislactam
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00357
Molecular Pharmaceutics
[ASAP] Usefulness of Optimized Human Fecal Material in Simulating the Bacterial Degradation of Sulindac and Sulfinpyrazone in the Lower Intestine
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00224
Molecular Pharmaceutics
[ASAP] The Shelf Life of ASDs: 1. Measuring the Crystallization Kinetics at Humid Conditions
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00188
Molecular Pharmaceutics
[ASAP] Voices in Molecular Pharmaceutics: Meet Dr. Vilmalí López-Mejías Who Finds Well-Behaved Solid-State Forms for Drug Development
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00437
Molecular Pharmaceutics
[ASAP] A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00092
Molecular Pharmaceutics
[ASAP] Effect of Vehicle Composition on the Preparation of Different Types of Dapsone Crystals for Topical Drug Delivery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00031
Molecular Pharmaceutics
[ASAP] <sup>124</sup>I Radiolabeled Basiliximab for CD25-Targeted Immuno-PET Imaging of Activated T Cells
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00330
Molecular Pharmaceutics
[ASAP] Investigation of Copper-64-Based Host–Guest Chemistry Pretargeted Positron Emission Tomography
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00102